Asthma

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue.

Importance of Compliance

New NHLBI Guideline Dissemination

LABA Trial Bias

Uncertainty of LABA Trial

Salmeterol vs. Formoterol

ICS Do Not Prevent Remodeling Discussion

Increase Death LABAs

Clinical Recommendations for asthma treatment

Preference for Symbicort HFA

Xopenex discussion

Advair vs. MED ICS

Financial trumps Clinical

Financial Recommendations in asthma category

Formulary Tradeoff

Tier 2 Costs higher than Tier 3

Co-Pay and Compliance

Clinical Trumps Financial

Impact of Generic on Contracts

Inappropriate LABA Utilization

Advair Delivery system

Symbicort Value

Symbicort New Formulation

Impact of Guidelines

Pending Generic

Contracts and Combo Products

Flovent vs. Pulmicort

Pro-Air vs. Ventolin

* PTP video clips play in windows media player. To download click here, Mac users click here.

top of page